At this week’s American Society for Mass Spectrometry in Denver meeting, Thermo Fisher Scientific introduced Proteome Discoverer, a new proteomics analysis software platform to provide researchers a view of their quantitative and qualitative proteomic data.
According to a company release, scientists using the software can combine and compare data from multiple search engines, public databases, and dissociation methods on a larger scale than previously possible. It analyzes data from all of Thermo Fisher’s mass spectrometers and is compatible with all of the standard proteomic workflows, according to the company.
“Proteome Discoverer is a complete workflow solution that offers a level of functionality that, up to now, would have required a complicated and expensive custom-built solution,” Andreas Hühmer, proteomics marketing director of Thermo Fisher Scientific, said in a statement.
Proteome Discoverer replaces Thermo Scientific BioWorks. Its analytical facets include Applied Biosystems’ iTRAQ and Thermo Fisher’s new TMT isotopic labeling strategy. TMT is a new Thermo product, but iTRAQ is an ABI product.
Also at ASMS, Bioinquire released ProteoIQ, a new software suite for analyzing proteomic data which, according to a company release supports the entire proteomic data analysis pipeline, including data organization, statistical validation, protein quantification, and publication/collaboration.
BioInquire was co-founded by University of Georgia researcher Ron Orlando who wanted to address the data handling bottleneck in his own lab studying proteins and glycoproteins.
ProteoIQ incorporates proprietary Protein Validation Technology (ProValT) algorithms licensed from the University of Georgia Research Foundation. This technology lets researchers assign a level of significance to their protein datasets, according to the company.
“The big idea behind ProteoIQ was to convert lists of protein identifications into a format that is easily understood and interpreted by biologists in a few mouse clicks,” said D. Brent Weatherly,CEO and co-founder of Bioinquire.
Definiens has introduced XD, a multi-dimensional image analysis platform. It helps with automated comparison of images from different modalities, such as in-vivo and in-vitro data, 2D and 3D images over time, and two-dimensional images to three-dimensional structures.
Tripos has released Benchware 3D Explorer Version 2.5, which according to a company release, gives life science researchers a better ability to collaborate and have 3D chemical visualization capability on their desktop computers.
Some of the software’s features include the capability to align protein structures along with their associated ligands to give scientists comparative views of data. Also, collaborative decision-making is provided by the 3D Explorer ActiveX control, which can now be purchased and installed separately from 3D Explorer.